3Kyprianou N, Tu H, Jacobs SC. Apoptptic versus proliferative activities in human benign prostatic hyperplasia [ J ]. Hum Pathol, 1996, 27(72): 668-675.
4Shapiro E, Becich M J, Hartanto V, et al. The relative proportion of stromal and epithelial hyperplasia is related to the development of symptomatic benign prostatic hyperplasia [ J]. J Urol,1992, 147(5) :1293-1297.
5Vacherot F, Azzouz M, Gil-Diez-de-Medin S, et al. Induction of apoptosis and inhibition of cell proliferation by the lipido-sterolic extract of serenoa repens (LSESr, Permixon) in Benign Prostatic Hyperplasia[ J ]. The Prostate, 2000, 45 (3) :259-266.
6Colombel M, Vacherot F, Gil Diez S, et al. Zonal variation of apoptosis and proliferation in the normal prostate and in benign prostatic hyperplasia[J]. Br J Urol, 1998, 82(3): 380-385.
7Matityahou A, Rosenzweig N, Golomb E, et al. Rapid proliferation of prostatic epithelial cells in spontaneously hypertensive rats: A model of spontaneous hypertension and prostate hyperplasia[J]. J Androl, 2003, 24(2): 263-269.
8Marinese D, Patel R, Walden PD, et al. Mechanistic investigation of the adrenergic induction of ventral prostate hyperplasia in mice[J]. Prostate, 2003, 54(3): 230-237.
9Golomb E, Rosenzweig N, Eilam R, et al. Spontaneous hyperplasia of the ventral lob of the prostate in aging genetically hypertensive rats[J]. J Androl, 2000, 21(1) :58-64.
10Tunn S, Nass R, Ekkernkamp A, et al. Evaluation of average life span of epithelial and stromal cells of human prostate by superoxide dismutase activity[J]. Prostate, 1989, 15 (3): 263-271.
